Pure Bioscience, Inc.
PURE· OTC
PUREPure Bioscience, Inc.
Filed Mar 16, 2012 · 10-Q · 45 days after period end · 0001079973-12-000152
| Metric | Q2 2012 | Q2 2011 |
|---|---|---|
| Revenue | $221.00K | $68.00K |
| Net Income | -$2.19M | -$2.48M |
| EPS Diluted | -$0.41 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
ended Jan 31, 2012 · filed Mar 16, 2012 · 45 d after period end
